Dec 31, 2025 • The Globe and Mail
BULLISH
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
Intuitive Surgical's single-port (SP) platform saw a 91% year-over-year growth in procedures during Q3 2025, driven by strong adoption in Korea and expanding indications in the U.S. This surge, coupled with regulatory advancements and positive clinical evidence, suggests SP surgery is transitioning from a niche to a more mainstream application, potentially serving as an incremental growth driver for the company. While the U.S. market is still in early stages, regulatory submissions and initial domestic use in new procedures like colorectal and thoracic surgeries are broadening its addressable market.
Dec 31, 2025 • MarketBeat
BULLISH
Ascent Group LLC Increases Stake in Stryker Corporation $SYK
Ascent Group LLC significantly increased its stake in Stryker Corporation by 124.4% in Q3, now owning 13,038 shares valued at approximately $4.82 million. This comes as Stryker reported strong quarterly earnings, exceeding EPS expectations and increasing its dividend, despite recent large insider selling activity. Institutional investors currently hold about 77.09% of the medical technology company's stock, while analysts maintain a "Moderate Buy" consensus rating.
Dec 30, 2025 • ts2.tech
SOMEWHAT-BEARISH
Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus
Stryker (SYK) shares closed down 0.5% in cautious year-end trading, with investors focused on a December 31st dividend record date and a January 1st leadership change as Spencer Stiles becomes President and COO. The stock is holding near a $350 support level, and the company has declared a quarterly dividend of $0.88 per share. The broader market also saw a pullback in the final week of 2025.
Dec 29, 2025 • MarketBeat
SOMEWHAT-BULLISH
Norris Perne & French LLP MI Has $16.69 Million Stock Holdings in Stryker Corporation $SYK
Norris Perne & French LLP MI significantly increased its stake in Stryker Corporation by 157.5% in Q3, now holding 45,153 shares valued at approximately $16.69 million. Despite institutional ownership reaching 77.09% and a "Moderate Buy" consensus rating from analysts, company insiders have recently sold a substantial volume of shares. Stryker also raised its quarterly dividend to $0.88, resulting in a 1.0% annualized yield.
Dec 29, 2025 • MarketBeat
NEUTRAL
Pacer Advisors Inc. Decreases Stock Position in Stryker Corporation $SYK
Pacer Advisors Inc. reduced its stake in Stryker Corporation by 11.6% in the third quarter of 2025, selling 3,650 shares and retaining 27,768 shares valued at approximately $10.27 million. This move comes amidst significant insider selling, with Director Ronda E. Stryker selling 276,173 shares and total insider sales reaching over $185 million in the past 90 days. Wall Street maintains a "Moderate Buy" rating for Stryker, with an average price target of $431.84, while the company recently increased its quarterly dividend to $0.88 per share.
Dec 29, 2025 • Nasdaq
NEUTRAL
Ex-Dividend Reminder: National Healthcare, Stryker and Annaly Capital Management
National Healthcare Corp. (NHC), Stryker Corp (SYK), and Annaly Capital Management Inc (NLY) are set to trade ex-dividend on December 31, 2025. Investors should expect a price reduction in shares of approximately 0.46% for NHC, 0.25% for SYK, and 3.03% for NLY, reflecting the upcoming quarterly dividend payments. The article provides historical dividend charts for each company to help assess dividend stability and estimated annual yields.